Two commonly used assays for the severity of prostate cancer performed equally well in a head-to-head trial. Medscape Medical News
Log in met Medi-Access
Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen
No Clear Winner in Trial of Tests for Low-Risk Prostate Cancer
Medscape: Urology | Geplaatst op 24.05.2022 23:16